Semin Thromb Hemost 2022; 48(01): 003-007
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III
1
Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia
,
2
Section of Clinical Biochemistry, University of Verona, Verona, Italy
› Institutsangaben
References
1
Favaloro EJ,
Lippi G.
Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19)—part I. Semin Thromb Hemost 2020; 46 (07) 757-762
2
Favaloro EJ,
Lippi G.
Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19)—part II. Semin Thromb Hemost 2021; 47 (04) 333-337
3 COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Accessed August 11, 2021 at: https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
4
Tregoning JS,
Flight KE,
Higham SL,
Wang Z,
Pierce BF.
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol 2021; 21 (10) 626-636
5
Sharma K,
Koirala A,
Nicolopoulos K,
Chiu C,
Wood N,
Britton PN.
Vaccines for COVID-19: where do we stand in 2021?. Paediatr Respir Rev 2021;S1526–0542(21)00065–8
6
Raman R,
Patel KJ,
Ranjan K.
COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies. Biomolecules 2021; 11 (07) 993
7 COVID-19 vaccines. Accessed August 11, 2021 at: https://en.wikipedia.org/wiki/COVID-19_vaccine
8
Lippi G,
Favaloro EJ.
Cerebral venous thrombosis developing after COVID-19 vaccination: VITT, VAT, TTS and more. Semin Thromb Hemost 2022; 48 (01) 8-14
9
Favaloro EJ.
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Int J Lab Hematol 2021; 43 (04) 559-570
10
Thachil J.
COVID-19 vaccine induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation. Semin Thromb Hemost 2022; 48 (01) 15-18
11
Bahraini M,
Dorgalaleh A.
The impact of SARS-CoV-2 infection on blood coagulation and fibrinolytic pathways: a review of prothrombotic changes caused by COVID-19. Semin Thromb Hemost 2022; 48 (01) 19-30
12
Hvas CL,
Larsen JB,
Adelborg K,
Christensen S,
Hvas A-M.
Dynamic hemostasis and fibrinolysis assays in intensive care COVID-19 patients and association with thrombosis and bleeding—a systematic review and a cohort study. Semin Thromb Hemost 2022; 48 (01) 31-54
13
Favaloro EJ,
Henry BM,
Lippi L.
Is lupus anticoagulant a significant feature of COVID-19? A critical appraisal of the literature. Semin Thromb Hemost 2022; 48 (01) 55-71
14
Favaloro EJ,
Henry BM,
Lippi L.
COVID-19 and antiphospholipid antibodies: time for a reality check?. Semin Thromb Hemost 2022; 48 (01) 72-92
15
Poredos P,
Poredos P.
Involvement of inflammation in venous thromboembolic disease: an update in the age of COVID-19. Semin Thromb Hemost 2022; 48 (01) 93-99
16
Abate V,
Casoria A,
Rendina D.
et al.
Spontaneous muscle hematoma in patients with COVID-19: a systematic literature review with description of an additional case series. Semin Thromb Hemost 2022; 48 (01) 100-108
17
Limami Y,
Khalki L,
Zaid N.
et al.
Oxford-AstraZeneca ChAdOx1 COVID-19 vaccine does not alter platelet aggregation. Semin Thromb Hemost 2022; 48 (01) 109-111
18
Fan BE,
Cheung C.
Post COVID-19 arterial thromboembolism: a clear and present danger. Semin Thromb Hemost 2022; 48 (01) 112-114
19
Fazio S,
Tufano A,
de Simone G.
Sustained high D-dimer in outpatients who have recovered from mild to moderate coronavirus disease 2019 (COVID-19). Semin Thromb Hemost 2022; 48 (01) 115-117
20
Weatherill A,
Laffan M,
Gasper G.
et al.
Impact of thrombosis and bleeding in patients with severe COVID-19 vs other viral pneumonias in the context of extracorporeal membrane oxygenation. Semin Thromb Hemost 2022; 48 (01) 118-123
21
Chiurazzi F,
Tufano A,
Esposito M,
D'Agostino F,
Casoria A,
Capasso F,
Di Minno G.
Acquired factor V inhibitor after coronavirus disease 2019 (COVID-19). Semin Thromb Hemost 2022; 48 (01) 124-126
22
Cittone MG,
Battegay R,
Condoluci A.
et al.
The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination. J Thromb Haemost 2021; 19 (09) 2360-2362
23
Lippi G,
Sanchis-Gomar F,
Favaloro EJ,
Lavie CJ,
Henry BM.
Coronavirus disease 2019-associated coagulopathy. Mayo Clin Proc 2021; 96 (01) 203-217
